Biofil Chemicals and Pharmaceuticals Limited engages in the pharmaceutical and chemical businesses primarily in India. More Details
Flawless balance sheet with solid track record.
Share Price & News
How has Biofil Chemicals and Pharmaceuticals's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: 524396's share price has been volatile over the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: 524396 exceeded the Indian Pharmaceuticals industry which returned 50.1% over the past year.
Return vs Market: 524396 exceeded the Indian Market which returned 2% over the past year.
Price Volatility Vs. Market
How volatile is Biofil Chemicals and Pharmaceuticals's share price compared to the market and industry in the last 5 years?
Simply Wall St News
No news available
Is Biofil Chemicals and Pharmaceuticals undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: 524396 (₹82) is trading above our estimate of fair value (₹0.52)
Significantly Below Fair Value: 524396 is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: 524396 is poor value based on its PE Ratio (98.7x) compared to the IN Pharmaceuticals industry average (23x).
PE vs Market: 524396 is poor value based on its PE Ratio (98.7x) compared to the Indian market (16.3x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate 524396's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: 524396 is overvalued based on its PB Ratio (7.4x) compared to the IN Pharmaceuticals industry average (2.2x).
How is Biofil Chemicals and Pharmaceuticals forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Pharmaceuticals & Biotech industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Biofil Chemicals and Pharmaceuticals has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
- Check out Biofil Chemicals and Pharmaceuticals's track record over time to understand how much the company has returned to shareholders and its earnings growth rate in the past.
- Biofil Chemicals and Pharmaceuticals competitive advantages and company strategy can generally be found in its financial reports archived here.
- Explore growth companies in the Pharmaceuticals & Biotech industry.
How has Biofil Chemicals and Pharmaceuticals performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 524396 has high quality earnings.
Growing Profit Margin: 524396's current net profit margins (4.6%) are higher than last year (2.6%).
Past Earnings Growth Analysis
Earnings Trend: 524396's earnings have grown by 3% per year over the past 5 years.
Accelerating Growth: 524396's earnings growth over the past year (160.5%) exceeds its 5-year average (3% per year).
Earnings vs Industry: 524396 earnings growth over the past year (160.5%) exceeded the Pharmaceuticals industry 14.7%.
Return on Equity
High ROE: 524396's Return on Equity (9.3%) is considered low.
How is Biofil Chemicals and Pharmaceuticals's financial position?
Financial Position Analysis
Short Term Liabilities: 524396's short term assets (₹322.7M) exceed its short term liabilities (₹274.8M).
Long Term Liabilities: 524396 has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: 524396's debt to equity ratio (8%) is considered satisfactory.
Reducing Debt: 524396's debt to equity ratio has reduced from 35.4% to 8% over the past 5 years.
Debt Coverage: 524396's debt is well covered by operating cash flow (87.5%).
Interest Coverage: 524396's interest payments on its debt are well covered by EBIT (41.6x coverage).
What is Biofil Chemicals and Pharmaceuticals's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate 524396's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate 524396's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if 524396's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if 524396's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of 524396's dividend in 3 years as they are not forecast to pay a notable one for the Indian market.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Ramesh Shah (84 yo)
Mr. Ramesh S. Shah serves as the Managing Director of Biofil Chemicals & Pharmaceuticals Ltd. and served as its Compliance Officer. Mr. Shah serves as the Chairman of Biofil Chemicals & Pharmaceuticals Ltd ...
|Chairman||no data||no data||4.88% |
|COO & Whole Time Director||0.17yr||₹1.74m||2.09% |
|Non-Executive Director||15.25yrs||no data||2.35% |
|Independent Director||17.75yrs||no data||no data|
|Independent Director||5.17yrs||no data||no data|
|Independent Director||0.17yr||no data||no data|
Experienced Board: 524396's board of directors are considered experienced (5.2 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Biofil Chemicals and Pharmaceuticals Limited's company bio, employee growth, exchange listings and data sources
- Name: Biofil Chemicals and Pharmaceuticals Limited
- Ticker: 524396
- Exchange: BSE
- Founded: 1985
- Industry: Pharmaceuticals
- Sector: Pharmaceuticals & Biotech
- Market Cap: ₹1.334b
- Shares outstanding: 16.27m
- Website: https://www.biofilgroup.net
Number of Employees
- Biofil Chemicals and Pharmaceuticals Limited
- B-12/B, Industrial Estate
- Madhya Pradesh
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|524396||BSE (Mumbai Stock Exchange)||Yes||Equity Shares||IN||INR||Dec 2001|
|BIOFILCHEM||NSEI (National Stock Exchange of India)||Yes||Equity Shares||IN||INR||Dec 2001|
Biofil Chemicals and Pharmaceuticals Limited engages in the pharmaceutical and chemical businesses primarily in India. The company offers basic drugs and chemicals, such as sodium chloride, potassium chlor ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/10/21 12:48|
|End of Day Share Price||2020/10/21 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.